Today: 30 June 2026
ASML stock jumps nearly 9% after analyst U-turn doubles target to $1,500
3 January 2026
1 min read

ASML stock jumps nearly 9% after analyst U-turn doubles target to $1,500

NEW YORK, January 3, 2026, 04:08 ET — Market closed.

ASML Holding N.V. shares climbed 8.7% in the last U.S. session, ending at $1,163.78 after a bullish analyst reversal helped propel the Dutch chipmaking equipment maker higher.

The move matters for investors because ASML sits at the critical step of making advanced semiconductors: lithography, the process used to print circuit patterns onto silicon wafers. When demand expectations shift for ASML’s tools, it tends to ripple across the broader chip cycle.

Chip stocks led the first trading day of 2026, with the Philadelphia SE Semiconductor index up 4%, while the Dow and S&P 500 finished higher and the Nasdaq ended little changed, a Reuters report said. Traders are also looking ahead to next week’s labor market data for fresh signals on interest rates.

Aletheia Capital analyst Warren Lau double upgraded ASML to “Buy” from “Sell” and lifted his price target to $1,500 from $750, TipRanks reported, calling it a Street-high target. TipRanks

In a research note cited by Investors.com, Lau pointed to stronger demand for ASML’s extreme ultraviolet systems and described deep ultraviolet orders from China as “resilient.” Investors

EUV, short for extreme ultraviolet, refers to lithography machines that use very short-wavelength light to etch the tiniest features needed for cutting-edge chips. DUV uses longer-wavelength light and is generally used for less-advanced manufacturing.

Investing.com reported that Aletheia expects ASML’s Low-NA EUV revenue to grow by roughly one-third in fiscal 2026 and accelerate in fiscal 2027, alongside a step-up in overall sales growth in those years. (“NA,” or numerical aperture, is a measure of how tightly a tool can focus light.) Investing

ASML’s jump came with strength across chip-equipment names, with Applied Materials up 4.6%, Lam Research up 8.1% and KLA up 4.9% in the last session.

ASML’s demand outlook is tied to capital spending at the biggest chipmakers, while trade policy remains a recurring overhang, particularly around exports to China.

Before the next session, investors will be watching next week’s U.S. employment data for any shift in the rates outlook, which can quickly change the market’s appetite for high-multiple chip stocks, Reuters reported.

ASML is scheduled to report fourth-quarter and full-year 2025 financial results on Jan. 28, according to the company’s investor calendar, and traders typically focus on new bookings — a measure of incoming orders — and management’s 2026 outlook.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020
Previous Story

Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Next Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

Go toTop